Literature DB >> 12758199

The mouse as a useful model of tuberculosis.

I M Orme1.   

Abstract

Like other animal models of tuberculosis, the mouse has provided a large amount of information that can be applied to understanding the disease process in infected humans. The model is particularly useful in providing information about the immune response, given the huge database of reagents now available, including antibodies to lymphocyte markers and the growing number of available gene disrupted mice, and the model is validated by the fact that multiple mechanisms discovered in the mouse such as the TH1 pathway and the Toll-like receptor system are similarly important in humans. The model also has its limitations, particularly in terms of the immunopathologic response, in which similar elements occur but are expressed somewhat differently.

Entities:  

Mesh:

Year:  2003        PMID: 12758199     DOI: 10.1016/s1472-9792(02)00069-0

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  42 in total

1.  BCG vaccination in the cotton rat (Sigmodon hispidus) infected by the pulmonary route with virulent Mycobacterium tuberculosis.

Authors:  Christine T McFarland; Lan Ly; Amminikutty Jeevan; Toshiko Yamamoto; Bradley Weeks; Angelo Izzo; David McMurray
Journal:  Tuberculosis (Edinb)       Date:  2010-05-06       Impact factor: 3.131

2.  Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Joanne Turner; Mercedes Gonzalez-Juarrero; Oliver C Turner; Ian M Orme
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.

Authors:  Ying Kong; Hequan Yao; Hongjun Ren; Selvakumar Subbian; Suat L G Cirillo; James C Sacchettini; Jianghong Rao; Jeffrey D Cirillo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Influence of vehicles used for oral dosing of test molecules on the progression of Mycobacterium tuberculosis infection in mice.

Authors:  Shubhra Singh; Richa Dwivedi; Vinita Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

5.  Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.

Authors:  Emily R Driver; Gavin J Ryan; Donald R Hoff; Scott M Irwin; Randall J Basaraba; Igor Kramnik; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

Review 6.  New drugs and regimens for treatment of TB.

Authors:  Eric Leibert; William N Rom
Journal:  Expert Rev Anti Infect Ther       Date:  2010-07       Impact factor: 5.091

7.  Capture of heat-killed Mycobacterium bovis bacillus Calmette-Guérin by intelectin-1 deposited on cell surfaces.

Authors:  Shoutaro Tsuji; Makiko Yamashita; Donald R Hoffman; Akihito Nishiyama; Tsutomu Shinohara; Takashi Ohtsu; Yoshimi Shibata
Journal:  Glycobiology       Date:  2009-01-29       Impact factor: 4.313

8.  Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.

Authors:  Scott T Nolan; Gyanu Lamichhane
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

9.  Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas.

Authors:  Smriti Mehra; Bapi Pahar; Noton K Dutta; Cecily N Conerly; Kathrine Philippi-Falkenstein; Xavier Alvarez; Deepak Kaushal
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

10.  The DosR regulon of M. tuberculosis and antibacterial tolerance.

Authors:  I L Bartek; R Rutherford; V Gruppo; R A Morton; R P Morris; M R Klein; K C Visconti; G J Ryan; G K Schoolnik; A Lenaerts; M I Voskuil
Journal:  Tuberculosis (Edinb)       Date:  2009-07-03       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.